CD274 and cancer: Having shown that this is possible across multiple cancer types, animal models and with multiple radiolabeled targeting agents now available, this section draws on how non-invasive information of PD-L1 status can be utilized to reveal aspects of PD-L1 biology, particularly its inherent spatial and temporal heterogeneity.